These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 32572902)
21. The c-Jun signaling pathway has a protective effect on nucleus pulposus cells in patients with intervertebral disc degeneration. Lei M; Wang K; Li S; Zhao K; Hua W; Wu X; Yang C Exp Ther Med; 2020 Nov; 20(5):123. PubMed ID: 33005249 [TBL] [Abstract][Full Text] [Related]
22. A selective inhibition of c-Fos/activator protein-1 as a potential therapeutic target for intervertebral disc degeneration and associated pain. Makino H; Seki S; Yahara Y; Shiozawa S; Aikawa Y; Motomura H; Nogami M; Watanabe K; Sainoh T; Ito H; Tsumaki N; Kawaguchi Y; Yamazaki M; Kimura T Sci Rep; 2017 Dec; 7(1):16983. PubMed ID: 29208967 [TBL] [Abstract][Full Text] [Related]
23. The role of quinazoline in ameliorating intervertebral disc degeneration by inhibiting oxidative stress and anti-inflammation via NF-κB/MAPKs signaling pathway. Chen ZB; Yu YB; Wa QB; Zhou JW; He M; Cen Y Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):2077-2086. PubMed ID: 32141577 [TBL] [Abstract][Full Text] [Related]
24. The Sirt1/P53 Axis in Diabetic Intervertebral Disc Degeneration Pathogenesis and Therapeutics. Zhang Z; Lin J; Nisar M; Chen T; Xu T; Zheng G; Wang C; Jin H; Chen J; Gao W; Tian N; Wang X; Zhang X Oxid Med Cell Longev; 2019; 2019():7959573. PubMed ID: 31583043 [TBL] [Abstract][Full Text] [Related]
25. An in vivo study of the effect of c-Jun on intervertebral disc degeneration in rats. Lei M; Zhao K; Hua W; Wang K; Li S; Wu X; Yang C Bioengineered; 2021 Dec; 12(1):4320-4330. PubMed ID: 34308759 [TBL] [Abstract][Full Text] [Related]
26. Suppression of monocyte chemoattractant protein 1, but not IL-8, by alprazolam: effect of alprazolam on c-Rel/p65 and c-Rel/p50 binding to the monocyte chemoattractant protein 1 promoter region. Oda T; Ueda A; Shimizu N; Handa H; Kasahara T J Immunol; 2002 Sep; 169(6):3329-35. PubMed ID: 12218154 [TBL] [Abstract][Full Text] [Related]
27. Retinoic acid inhibits the pyroptosis of degenerated nucleus pulposus cells by activating Sirt1-SOD2 signaling. Li PF; Xiong F; Xing HY; Hu SJ; Zhang N Connect Tissue Res; 2023 Jul; 64(4):337-349. PubMed ID: 37004174 [TBL] [Abstract][Full Text] [Related]
28. S-phase kinase-associated protein-2 (Skp2) promotes nucleus pulposus cell proliferation by inhibition of p27 in attenuating intervertebral disc degeneration. Cui ZY; Shen L; Gao XS; Dong XB; Fu HY Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2802-2810. PubMed ID: 32271397 [TBL] [Abstract][Full Text] [Related]
29. Bone morphogenetic protein 2 alleviated intervertebral disc degeneration through mediating the degradation of ECM and apoptosis of nucleus pulposus cells via the PI3K/Akt pathway. Tan Y; Yao X; Dai Z; Wang Y; Lv G Int J Mol Med; 2019 Jan; 43(1):583-592. PubMed ID: 30387830 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-7 regulates IL-1β-induced extracellular matrix degeneration by targeting GDF5 in human nucleus pulposus cells. Liu W; Zhang Y; Xia P; Li S; Feng X; Gao Y; Wang K; Song Y; Duan Z; Yang S; Shao Z; Yang C Biomed Pharmacother; 2016 Oct; 83():1414-1421. PubMed ID: 27583982 [TBL] [Abstract][Full Text] [Related]
31. Xylosyltransferase-1 expression is refractory to inhibition by the inflammatory cytokines tumor necrosis factor α and IL-1β in nucleus pulposus cells: novel regulation by AP-1, Sp1, and Sp3. Ye W; Zhou J; Markova DZ; Tian Y; Li J; Anderson DG; Shapiro IM; Risbud MV Am J Pathol; 2015 Feb; 185(2):485-95. PubMed ID: 25476526 [TBL] [Abstract][Full Text] [Related]
32. Sirtuin 1 participates in intervertebral disc degeneration via the nicotinamide phosphoribosyl transferase/nicotinamide adenine dinucleotide/sirtuin 1 pathway responsible for regulating autophagy of nucleus pulposus cells. Shi Q; Xu L; Zeng X Exp Ther Med; 2022 Apr; 23(4):267. PubMed ID: 35251333 [TBL] [Abstract][Full Text] [Related]
33. SIRT1 expression is refractory to hypoxia and inflammatory cytokines in nucleus pulposus cells: Novel regulation by HIF-1α and NF-κB signaling. Wang X; Li H; Xu K; Zhu H; Peng Y; Liang A; Li C; Huang D; Ye W Cell Biol Int; 2016 Jun; 40(6):716-26. PubMed ID: 27061137 [TBL] [Abstract][Full Text] [Related]
34. IL-1β increases asporin expression via the NF-κB p65 pathway in nucleus pulposus cells during intervertebral disc degeneration. Wang S; Liu C; Sun Z; Yan P; Liang H; Huang K; Li C; Tian J Sci Rep; 2017 Jun; 7(1):4112. PubMed ID: 28646230 [TBL] [Abstract][Full Text] [Related]
35. Piperine mediates LPS induced inflammatory and catabolic effects in rat intervertebral disc. Li Y; Li K; Hu Y; Xu B; Zhao J Int J Clin Exp Pathol; 2015; 8(6):6203-13. PubMed ID: 26261497 [TBL] [Abstract][Full Text] [Related]
36. [Restoring phenotype of dedifferentiated normal nucleus pulposus cells by resveratrol]. Shen J; Hu Z; Zhong X; Wang D; Xu L Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 May; 27(5):547-53. PubMed ID: 23879090 [TBL] [Abstract][Full Text] [Related]
37. Hyperbaric oxygen treatment suppresses MAPK signaling and mitochondrial apoptotic pathway in degenerated human intervertebral disc cells. Niu CC; Lin SS; Yuan LJ; Chen LH; Wang IC; Tsai TT; Lai PL; Chen WJ J Orthop Res; 2013 Feb; 31(2):204-9. PubMed ID: 22886767 [TBL] [Abstract][Full Text] [Related]
38. Recombinant human SIRT1 protects against nutrient deprivation-induced mitochondrial apoptosis through autophagy induction in human intervertebral disc nucleus pulposus cells. Miyazaki S; Kakutani K; Yurube T; Maeno K; Takada T; Zhang Z; Kurakawa T; Terashima Y; Ito M; Ueha T; Matsushita T; Kuroda R; Kurosaka M; Nishida K Arthritis Res Ther; 2015 Sep; 17(1):253. PubMed ID: 26373839 [TBL] [Abstract][Full Text] [Related]
39. Preclinical development of a microRNA-based therapy for intervertebral disc degeneration. Ji ML; Jiang H; Zhang XJ; Shi PL; Li C; Wu H; Wu XT; Wang YT; Wang C; Lu J Nat Commun; 2018 Nov; 9(1):5051. PubMed ID: 30487517 [TBL] [Abstract][Full Text] [Related]
40. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition. Chen YM; Chiang WC; Lin SL; Wu KD; Tsai TJ; Hsieh BS J Pharmacol Exp Ther; 2004 Jun; 309(3):978-86. PubMed ID: 14978197 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]